Elk Petroleum offers an attractive production growth profile from Enhanced Oil Recovery operations in the US and DJ Carmichael initiates coverage with a Buy rating.
Bionomics has moved into the cancer stem cell field through a US acquisition and on the news Bell Potter reiterates its Buy rating for the stock.
Despite a drug crystallisation issue pushing back its testing timeline, Phosphagenics continues to offer upside through its drug patch delivery technology in the view of Bell Potter.
Bell Potter quite likes Neuren Pharmaceuticals because of progress with drugs for Traumatic Brain Injury and Autism Spectrum Disorders, plus developments in a Parkinson’s Disease compound offer.
Macquarie has initiated coverage on junior telco Amcom with an Outperform rating, attracted to expected double-digit earnings growth as the group’s cloud and fibre services expand.
Cleveland Mining is developing gold and iron ore projects in Brazil and following a site visit DJ Carmichael initiates coverage with a Speculative Buy rating.
HR group Chandler Macleod posted a solid full year profit result and given expectations of further growth Moelis retains a Buy rating.
Algae to biofuel pioneer Algae.Tec has passed a first production milestone at its Nowra demonstration facility.
Assets in both the US and Vietnam appear highly prospective and DJ Carmichael sees enough potential upside in Neon Energy to rate the stock a ‘High Conviction’ Speculative Buy.
With a number of potential catalysts in coming months and on the back of recent share price weakness, DJ Carmichael reiterates a Speculative Buy rating on Jacka Resources.